Edition:
United States

People: Johnson & Johnson (JNJ)

JNJ on New York Consolidated

125.80USD
27 Mar 2017
Change (% chg)

$0.32 (+0.26%)
Prev Close
$125.48
Open
$125.16
Day's High
$126.14
Day's Low
$125.15
Volume
5,004,285
Avg. Vol
7,220,658
52-wk High
$129.00
52-wk Low
$107.69

Peterson, Sandra 

Ms. Sandra E. Peterson is Executive Vice President - Group Worldwide Chairman of Johnson & Johnson. Ms. Peterson oversees the Consumer and Consumer Medical Device businesses; the Company's operating infrastructure — Supply Chain, Information Technology, Global Services; Health & Wellness; Global Design; and Health Technology. Prior to joining the Company, Ms. Peterson was Chairman and Chief Executive Officer of Bayer CropScience AG in Germany, previously serving as President and Chief Executive Officer of Bayer Medical Care and President of Bayer HealthCare AG's Diabetes Care Division. Before joining Bayer in 2005, Ms. Peterson held a number of leadership roles at Medco Health Solutions (previously known as Merck-Medco). In April 2016. Ms. Peterson was named Executive Vice President, Group Worldwide Chairman of Johnson & Johnson. Effective June 1, 2017, Ms. Peterson will assume leadership of the Hospital Medical Device business, in addition to her current responsibilities.

Basic Compensation

Total Annual Compensation, USD 2,033,650
Restricted Stock Awards, USD 3,504,180
Long-Term Incentive Plans, USD --
All Other, USD 2,088,620
Fiscal Year Total, USD 7,626,450

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

23,795,900

Dominic Caruso

9,689,400

Sandra Peterson

7,626,450

Peter Fasolo

3,621,280

Paulus Stoffels

10,785,700

Michael Ullmann

5,676,350
As Of  31 Dec 2016